Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma

14 Jul 2023

Abstract excerpt

Abstract Background Current knowledge on apolipoprotein A1 (APOA1) in hepatocellular carcinoma (HCC) is fragmented and even contradictory. Multi-dimensional analyses are required to comprehensively elucidate its value and underlying mechanism. Methods We collected 49 RNA-seq datasets, 40 cell line types data and 70 scRNA pan-cancer datasets public available, including 17 HCC datasets (1754 tumor samples), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38025972
DOI: 10.1093/pcmedi/pbad021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinomaPMID 38025972Read ↗

Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.Semantic proximity Read ↗

Integrating single-cell and bulk RNA-seq to reveal cholesterol homeostasis-related genes via machine learning to predict prognosis and therapeutic response in hepatocellular carcinomaSemantic proximity Read ↗

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.Semantic proximity Read ↗

Investigation of mitochondrial DNA methylation-related prognostic biomarkers in hepatocellular carcinoma using The Cancer Genome Atlas (TCGA) databaseSemantic proximity Read ↗

ARID1A mutation is associated with an immunosuppressive microenvironment and poor prognosis in hepatocellular carcinoma: An integrated bioinformatics analysis.Semantic proximity Read ↗

BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular CarcinomaSemantic proximity Read ↗

Apolipoprotein C1 as a Novel Biomarker for Evaluating Immunotherapy Drug Responses and Clinical Prognosis for Microsatellite Unstable Colorectal CancerSemantic proximity Read ↗

Integrated genomic analyses of hepatocellular carcinoma.Semantic proximity Read ↗

Deciphering m6A signatures in hepatocellular carcinoma: Single‐cell insights, immune landscape, and the protective role of IGFBP3Semantic proximity Read ↗

RNA-Seq Profiling Revealed PBMC RNA as Potential Biomarker for Hepatocellular CarcinomaSemantic proximity Read ↗

APOA1 as a Potential Therapeutic Target and Novel Biomarker in Lung AdenocarcinomaSemantic proximity Read ↗

Identification and validation of AKR1C1/2/3 as hepatocellular carcinoma risk modules via an integrated strategySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.